Results 1 to 10 of about 27,684 (225)

MUC1 as a Survival Effector of Radiotherapy-Induced Epithelial Hybrid States in Basal-Like Breast Cancer. [PDF]

Int J Cancer
Basal‐like breast cancer (BLBC) is aggressive and often exhibits inherent or acquired resistance to radiotherapy (RT), a primary treatment option. RT resistance is underpinned by molecular alterations, many of which are poorly understood. Here, RT‐induced transcriptomic changes were analyzed using bulk and spatial sequencing in a BLBC mouse model and ...
Pantelaiou-Prokaki G, Bamahmoud H, Georges NS, Jansari S, Jung A, Grimm D, Prokakis E, Gayer FA, Deldar M, Dullin C, Gallwas J, Wegwitz F, Alves F.   +12 more
europepmc   +2 more sources

Comparison of immediate therapeutic effects of 3% diquafosol and 2% rebamipide in dry eye disease: a prospective, randomized, paired-eye trial. [PDF]

Sci Rep
Song MS, Kim E, Park N, Eom Y, Song JS, Kim DH.   +5 more
europepmc   +1 more source

An in vitro approach for simulating divergent Golgi O-glycosylation of tumor-associated MUC1 from normal MUC1. [PDF]

Nat Commun
Nashed A, Dilsook K, Senapathi T, Naidoo KJ.   +3 more
europepmc   +1 more source

Triple-Mutated HSV-1 Expressing Soluble B7-1 Plus CTLA-4 Blockade Suppresses Lymph Node Metastasis in Tongue Cancer. [PDF]

Cancer Sci
Sugauchi A, Uchihashi T, Ito H, Iwai M, Tsurumaki Sato Y, Kurioka K, Usta SZ, Tanaka M, Kogo M, Tanaka S, Fukuhara H, Todo T.   +11 more
europepmc   +1 more source

The Overexpression of Myelin and Lymphocyte Protein (MAL) Downregulates MUC1 and Enhances Cisplatin Sensitivity in Non-Small Cell Lung Cancer Cells. [PDF]

J Cancer
Saldaña-Villa AK, Vázquez-Almazán B, Flores-Maldonado C, Vizuet-de-Rueda JC, Oropeza-Durán EN, Bonilla-Delgado J, Cortés-Malagón EM, Contreras RG, Teran LM, Ortiz-Quintero B, Lara-Lemus R.   +10 more
europepmc   +1 more source

Autosomal Dominant Tubulointerstitial Kidney Disease Clinical Trial Simulator: Case Reports of Model-Informed Drug Development. [PDF]

CPT Pharmacometrics Syst Pharmacol
Ramesh SS, Rogge M, Kim J, Kang S, Kidd K, Williams A, Roignot J, Blakeslee K, Bleyer AJ, Kim S.   +9 more
europepmc   +1 more source

Editorial: Cancer Immunosurveillance. [PDF]

Front Immunol
Hanash S, Buonaguro L, Finn O.
europepmc   +1 more source

Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway. [PDF]

Bioact Mater
Zou B, Li S, Luk KH, Dong X, Chun-Him Lai N, Cheng WY, Liu G, Wong KH, Chen T.   +8 more
europepmc   +1 more source

A Review of Recent Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hepatocellular Carcinoma. [PDF]

Med Sci Monit
Lv X, Chen X, Ge Y, Si G, Li Y, Li X, Yuan X.   +6 more
europepmc   +1 more source

A MUC1-ALIX complex regulates extracellular vesicle cargo loading with activated SRC to enhance pancreatic cancer progression. [PDF]

Cancer Lett
Huang Y, Hoagstrom KV, Mundry CS, Hu T, Jensen-Smith HC, Wragge J, Le P, Baniya A, McAndrews KL, Caffrey TC, O'Connell KA, Singh PK, Triplett AA, Grandgenett PM, Hollingsworth MA.   +14 more
europepmc   +1 more source